Alembic Pharmaceuticals acquires UTILITY therapeutics

Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya to treat uUTIs.

Jul 7, 2025 - 06:00

Alembic Pharmaceuticals acquires UTILITY therapeutics

Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya to treat uUTIs.

Read the original article

Tags:

Previous Article

Mushrooms and Cancer — Can They Help?

CDMO insights podcast series: Our Experience is Your Strength | Episode #1 Formu...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

J&J-backed Bright Peak secures $90m to advance immunoconjugate programme

J&J-backed Bright Peak secures $90m to advance immunoco...

Jun 12, 2024

STAT+: Pharmalittle: Pfizer and Valneva delay application for Lyme vaccine; Moderna adjusts price for Covid-19 shot

STAT+: Pharmalittle: Pfizer and Valneva delay applicati...

May 5, 2023

Nuance’s mysterious pricing, speedier digital health evidence reviews, and new breakthrough devices

Nuance’s mysterious pricing, speedier digital health ev...

Jun 2, 2023